OPEN END TURBO BULL OPTIONSSCHEIN - BIOGEN IDEC | Real-time BOERSE MUENCHEN 01:40:48 2024-07-17 pm EDT | ||
| 4.99 EUR | +8.95% |
|
| Current month | -11.75% | ||
| 1 month | -16.27% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-07-17 | 4.99 | +8.95% |
| 24-07-16 | 4.58 | +4.57% |
| 24-07-15 | 4.38 | -12.92% |
| 24-07-12 | 5.03 | -11.13% |
| 24-07-11 | 5.66 | +7.60% |
Real-time BOERSE MUENCHEN
Last update July 17, 2024 at 01:40 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD2RPP |
| ISIN | DE000HD2RPP3 |
| Date issued | 2024-02-16 |
| Strike | 176.7 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 5.32 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.94 € |
|---|---|
| Lowest since issue | 1.75 € |
| Spread | 0.01 € |
| Spread % | 0.20% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
225
USD
Average target price
281.2
USD
Spread / Average Target
+24.96%
- Stock Market
- Certificates
- Certificat
